Le Lézard
Classified in: Science and technology
Subjects: LAW/LEGAL ISSUES, GOVERNMENT CONTRACTS

Altai Reports on Bill 21


TORONTO, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Altai Resources Inc. (ATI, TSX VENTURE; US SEC Rule 12g3-2(b) File # 82-2950) (the "Company" or "Altai") reports that the Quebec Government has announced that Bill 21, An Act mainly to end petroleum exploration and production and the public financing of those activities, introduced on February 2, 2022 and assented to on April 13, 2022 ("Bill 21"), will come into effect on August 23, 2022.

In March 2022, the Company filed a claim in the Superior Court of Quebec against the Minister of Energy and Natural Resources of Quebec and the Quebec Government, as represented by the Attorney-General for Quebec (collectively the "Defendants") to defend the Company's rights and to seek compensation from the Defendants for the illegal expropriation of its Quebec oil and gas licences by the Defendants by the enactment of the Petroleum Resources Act and its Regulations, the Defendants' subsequent unlawful application of same, and their intended completion of this illegal expropriation with Bill 21. To date, the said claim is ongoing.

The Company has been working in the oil and gas industry in Quebec, Canada for more than thirty years, has entered into many different licence agreements with the Defendants, and has incurred vast expenditures in the exploration and development of its oil and gas licences at the encouragement of the Defendants and with their assurances that the rights of explorers to explore and exploit their discoveries would be respected.

ABOUT ALTAI
Altai Resources Inc. is a resource company with a producing oil property in Alberta and exploration gold and gas properties in Quebec, Canada.

For further information, please contact
Maria Au, Secretary-Treasurer

Tel: (416) 383-1328 Fax: (416) 383-1686
Email: [email protected]  Internet: http://www.altairesources.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



These press releases may also interest you

at 07:05
Diligent, a leading GRC SaaS company, today announced a first-of-its-kind Enterprise Risk Management (ERM) dashboard powered by industry-leading market data from Moody's , the leading source of relevant insights on exponential risk. The dashboard...

at 07:05
908 Devices Inc. , a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences. 2024 Leerink Partners Healthcare Crossroads Conference,...

at 07:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Leerink Partners Healthcare Crossroads Conference...

at 07:05
D-Wave Quantum Inc. ("D-Wave"), a leader in quantum computing systems, software, and services, today announced it is participating in the upcoming Reuters Supply Chain USA 2024 conference, reflecting the company's focus on addressing optimization...

at 07:05
Blackstone today announced the launch of the Blackstone Life Sciences ("Blackstone") portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation. Uniquity Bio is emerging from stealth with an FDA...

at 07:05
Rondo Therapeutics, a biopharmaceutical company pioneering next-generation bispecific antibodies, announces oral presentations at both Protein & Antibody Engineering Summit (PEGS) and Antibody Engineering & Therapeutics (AET) EU. Rondo Therapeutics...



News published on and distributed by: